Most Read Articles
5 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 4 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
5 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.

Exposure to pharmacists may shorten time to treatment intensification in T2D patients

08 Nov 2019
Healthcare professionals should spend sufficient amount of time with their patients in order to elicit information on barriers to medication adherence.

Patients with type 2 diabetes (T2D) who are exposed to a pharmacist have a shorter time to treatment intensification and a greater decrease in A1C compared with those managed solely by a medical provider, according to a study. Results, however, are not statistically significant.

Fifty patients with T2D were included in the study and were divided into pharmacist–physician managed (PPM) or usual medical care (UMC) cohorts.

The UMC cohort experienced significantly longer mean time to treatment intensification than the PPM cohort (325 vs 200 days; p=0.50).

There were more patients in the PPM cohort who achieved ≥0.5-percent reduction in A1C as compared to those in the UMC cohort (60 percent vs 44 percent; p=0.41). In addition, the PPM cohort had a greater mean decrease in A1C from baseline than did those in the UMC cohort (–1 percent vs –0.4 percent; p=0.24).

“Additional research is needed to evaluate the role of the pharmacist in improving clinical inertia in the management of T2D,” the authors said.

This retrospective matched cohort study at two academic family medicine clinics examined time to treatment intensification and changes in A1C among PPM patients compared to UMC patients with T2D. Individuals in each arm were matched 1:1 based on age, gender, race and primary care provider.

“Achievement of treatment goals for patients with T2D is suboptimal,” the authors said. “This is in part driven by a lack of treatment intensification when warranted, termed ‘clinical inertia’.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 4 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
5 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.